Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update
January 16, 2019 08:28 ET
|
Viveve Medical, Inc.
- Company reports $18.5 million in preliminary full year 2018 revenue, representing 21% year-over-year growth, and announces revenue guidance of $20.0 million for 2019 - Company undergoes...
Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
January 03, 2019 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, announced today that it has completed...
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
December 20, 2018 16:50 ET
|
Viveve Medical, Inc.
- Sites to continue enrollment up to 250 patients in sexual function trial - ENGLEWOOD, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company...
Viveve Announces Closing of Public Offering of Shares of Common Stock
December 11, 2018 16:05 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of...
Viveve Announces Pricing of Public Offering of Shares of Common Stock
December 06, 2018 21:49 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the pricing of an...
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
December 06, 2018 16:03 ET
|
Viveve Medical, Inc.
— 72% of women treated experienced an improvement in the one-hour pad weight with an overall mean improvement of 56% — Clinically meaningful benefit achieved at one year across all...
Viveve Announces Proposed Public Offering of Shares of Common Stock
December 06, 2018 16:01 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that it has...
Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
November 29, 2018 08:28 ET
|
Viveve Medical, Inc.
Twelve-month data from the SUI feasibility study to be presented ENGLEWOOD, Colo., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte
November 15, 2018 16:28 ET
|
Viveve Medical, Inc.
Company awarded sixth place overall and is only medical device company listed in the top ten ENGLEWOOD, Colo., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical...
Viveve to Present at Stifel 2018 Healthcare Conference
November 08, 2018 17:30 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief...